Innate Pharma appoints Marcel Rozencweig, MD, as Senior Vice President, clinical and regulatory strategy Sofinnova

The News

Innate Pharma appoints Marcel Rozencweig, MD, as Senior Vice President, clinical and regulatory strategy

27/04/2009

Marseilles, France, April 27, 2009
Innate Pharma S.A. (Euronext Paris: FR0010331421 – IPH) announces today the strengthening of its management team with the appointment of Marcel Rozencweig, MD, as Senior Vice President in charge of clinical and regulatory strategy.

Dr. Rozencweig is recognized as a world leading expert and opinion leader in medical oncology and anti-cancer drug development. He built and led the clinical research group at Bristol-Myers Squibb (“BMS”) that developed all the NCEs brought by BMS to the market from 1983 to 2001 in the area of cancer (including carboplatin and paclitaxel).

Visit website www.innate-pharma.com

2009

08/01/2009
Ablynx strengthens management team with the appointment of Dr Debbie Law as Chief Scientific Officer
09/01/2009
CoreValve Prevails in United Kingdom Patent Infringement Action
13/01/2009
Inside Contactless Named “Red Herring 100 Global” Finalist
13/01/2009
Thomas Gebauer joins ReVolt Technology, Ltd as CFO
14/01/2009
Ablynx announces technical advances in its NANOBODY® platform technology: enhanced benefits from pulmonary delivery and half-life extension
15/01/2009
ReVolt Technology, Ltd Receives Additional 10 Million Euro B Round Investment
16/01/2009
Purple Labs Closes 52 Million Euro License And Development Agreement Following Acquisition Of Sagem Mobile Software
20/01/2009
ReVolt Technology, Ltd Forms Technical Advisory Board
21/01/2009
Ablynx expands its musculoskeletal portfolio by taking P&G pharmaceuticals' programme in-house
21/01/2009
Vivalis and Innate Pharma sign a collaboration and commercial license agreement to develop Innate's novel monoclonal antibody, to be manufactured with vivalis'EB66® platform, for rare cutaneous cancers
21/01/2009
DBV Technologies raises €6 million (EUR) in Series B investment and secures new corporate investor
21/01/2009
Vivalis et Innate Pharma signent un accord de collaboration et de licence commerciale pour le développement d'un nouvel anticorps d'Innate produit sur la plateforme EB66® pour le traitement de cancers cutanés rares
22/01/2009
Emailvision, 1er éditeur international des logiciels «SaaS» pour la gestion et l’optimisation des campagnes d’e-mail marketing, publie son chiffre d’affaires 2008.
28/01/2009
Addex Successfully Completes ADX48621 Phase I Program
28/01/2009
PC 30 - journal télévisé France 2 - 26 déc
04/02/2009
Inside Contactless and Sagem Wireless extend NFC Technology Partnership
05/02/2009
String of Achievements Reinforces Company’s Leadership Role
11/02/2009
NFC Technology Part of Qualcomm 3G Handset Reference Designs,
13/02/2009
Esmertec to acquire Purple Labs creating Europe’s largest mobile phone software company
23/02/2009
Sofinnova Partners realizes impressive exit with sale of portfolio company CoreValve to Medtronic
23/02/2009
Sofinnova Partners réussit la sortie de CoreValve : vente à Medtronic pour un montant initial de 700 millions de dollars
17/02/2009
Tech tour seeks 'Best of French' emerging technology companies
05/03/2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
05/03/2009
GlycoVaxyn AG lève CHF 25 Million d’argent frais
03/03/2009
Novexel’s NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients with complicated Intra- Abdominal Infections (cIAIs)
03/03/2009
Novexel débute une deuxième étude clinique de phase II sur l’association NXL104/ceftazidime chez des patients hospitalisés atteints d’infections intra-abdominales compliquées
10/03/2009
EOS (Ethical Oncology Science) Closes an € 8.2 Million (US$ 10 Million) Series A Financing to Advance Innovative Targeted Cancer Therapies
12/03/2009
Acute myocardial infarction (AMI) successfully treated with Stentys self-expanding platform,solving stent-malapposition
17/03/2009
PC30 annonce le rachat de la société SMARTFIX aux Pays-Bas
25/03/2009
Sofinnova Partners Voted 2008 “European Venture Capital Firm of the Year”
25/03/2009
Sofinnova Partners élu « Société de capital-risque européenne de l'année 2008 »
30/03/2009
Ablynx reports detailed positive phase Ib results for its anti-thrombotic Nanobody® ALX-0081
31/03/2009
First Data and Inside Contactless launch partnership for go-tag payment sticker technology
02/04/2009
Paris, le 2 avril 2009 - PC30 | Comptes 2008
08/04/2009
PC30 - Challenges
15/04/2009
Travel technology leader Sprice.com to power Sify's travel search
20/04/2009
UPEK and WinMagic Announce Biometric Authentication and Hard Disk Encryption Solution for SMBs Eikon Fingerprint Reader ...
13/04/2009
PC 30 | ITÉLÉ 13 AVRIL 09 20H30-21H - Vive les entreprises de service ?
21/04/2009
Neosens closes a second funding round of €4M
27/04/2009
Innate Pharma appoints Marcel Rozencweig, MD, as Senior Vice President, clinical and regulatory strategy
27/04/2009
Innate Pharma nomme le Docteur Rozencweig au poste de Senior Vice Président, stratégie clinique et réglementaire
29/04/2009
LITTLETON, Colorado, April 29, 2009 – CPI Card Group (CPI), a global leader in financial and commercial card production and services, and INSIDE Contactless, a leading provider of advanced, open-standard contactless chip technologies, today announced they
07/05/2009
Ablynx announces that its VWF NANOBODY® programme has been granted orphan drug designation and provides a business update for the first quarter 2009
11/05/2009
HRA pharma and Preglem announce successful completion of phase IIB for ulipristal acetate for the treatment of uterine fibroids
15/05/2009
UPEK Wins TiE50 Award
27/05/2009
U.S. Bank first to offer a single visa card for identification, purchases and secure facility access
28/05/2009
Inside debuts converged contactless payment/access control platform
30/05/2009
Innate Pharma reports preliminary phase I clinical data for IPH 2101 (a novel, anti-kir monoclonal antibody activating NK celles) at the ASCO meeting
02/06/2009
Consumers “Tap” Over One Million Mobile Searches Daily
28/05/2009
HID Global Together with INSIDE Contactless Debut Converged Platform for Access Control and Payment Solutions
02/06/2009
Myriad Group AG announces Q1 revenue of USD 30 million
02/06/2009
UPEK Unveils Fingerprint Sensor with Integrated LEDs
08/06/2009
NOXXON Announces Initiation of First Clinical Trial with a Spiegelmer®
19/06/2009
ReVolt Technology Selected as a Top-24 European Cleantech Leader
18/06/2009
Sprice.Com Teams Up With AsiaOne
22/06/2009
blueKiwi lève 3 millions d'euros auprès de Dassault Systèmes
23/06/2009
Takeda Establishes "Takeda Global Advisory Board"
22/06/2009
Sofinnova Partners Leads Investment Round in CoAxia
26/06/2009
Ablynx wins european mediscience award for best technology
29/06/2009
Innate Pharma reports positive phase IIa clinical results for IPH 1101 (ãä T CELL AGONIST) in type C viral hepatitis
29/06/2009
Innate Pharma annonce des r¨¦sultats de phase IIa positifs avec IPH 1101 (agonistedes lymphocytes T ¦Ã¦Ä) dans l'h¨¦patite virale de type C
02/07/2009
PC30 reprend les activités « desktop » de SOGETI en Ile de France
02/07/2009
Ablynx promoted to the belgian MID-CAP-INDEX
06/07/2009
Blue Kiwi | The Europas Shortlist: Best Enterprise / B2B Startup
08/07/2009
Stentys receives CE Mark approval
09/07/2009
ReVolt Technology, Ltd & BASF Announce Joint Development Agreement for Rechargeable Zinc-Air Battery
09/07/2009
Maurice Petitou, Directeur de la Recherche chez Endotis Pharma, Lauréat du Prix Charles Mentzer pour ses découvertes et le développement d’oligosaccharides de synthèses dans la maladie thromboembolique
09/07/2009
Maurice Petitou, Head of Preclinical Research & Development at Endotis Pharma, wins the Charles Mentzer Prize for his discoveries on synthetic oligosaccharides in thrombosis
15/07/2009
INTERAC® Partners with Global Leader INSIDE to bring Contactless Debit to Canada
27/07/2009
Movetis receives positive opinion by the CHMP on European Marketing Authorisation Application for Resolor® (prucalopride) indicated for the treatment of Chronic Constipation
27/07/2009
Orange to offer free gifts to students who agree to receive ads on mobiles
21/07/2009
Multek Enhances Touch Screen Solution Through Sensitive Object Strategic Alliance
30/07/2009
EOS (Ethical Oncology Science) Closes Series A Financing with new Investor AESCAP Venture joining Sofinnova Partners and Quantica SGR
30/07/2009
Renforcement du conseil de surveillance de PC30 Jean Marie Descarpentries nommé Président
13/08/2009
Inside Contactless and cryptography research sign agreement to license DPA patents
12/08/2009
Upek launches developer contest for Windows 7 Biometric applications
12/08/2009
Richard L. Middaugh Joins ReVolt Technology Advisory Board
18/08/2009
Orexo announces that its partner Meda has initiated the launch of EdluarTM in the USA
18/08/2009
Ablynx announces positive Phase I results for subcutaneous administration of its ANTI-THROMBOTIC NANOBODY® (ALX-0681)
18/08/2009
Myriad Delivers Services Platform for Customer Service to T-Mobile
27/08/2009
Ablynx announces half-year results for 2009
28/08/2009
Orexo signs exclusive worldwide license agreement for a novel formulation
27/08/2009
Start of the first phase II clinical trial with monoclonal antibody IPH 2101 supported by a new 2.9 millions euros financing from OSEO
28/08/2009
Stentys appoints Vice President of Sales and Marketing
01/09/2009
ReVolt Technology Applies for $30 million in Government Research Grants Accelerating Development of Innovative Zinc-Air Batteries for Vehicles and Renewable Energy Storage Company selects Portland, Oregon as location for US HQ & R&D Center
01/09/2009
Ablynx inititates Phase II clinical trial for ALX-0081
03/09/2009
NOXXON Is Awarded Research and Development Grant for First-in-Human Clinical Trial with Spiegelmer® NOX-A12
01/09/2009
Myriad Appoints James Bodha as New Chief Financial Officer
08/09/2009
Inside Contactless and Connecthings team to take NFC to the next level
09/09/2009
ReVolt Technology named a Global Cleantech 100 clean technology company
09/09/2009
Neosens named a Global Cleantech 100
10/09/2009
SFR a sélectionné WYPLAY pour sa prochaine génération de décodeurs TV
10/09/2009
SFR selects WYPLAY for its next generation of HD IP-STB
09/09/2009
Engel and Wyplay parnter for next generation connected HD STB
11/09/2009
Myriad Introduces World’s First Widget Solution for Ultra-Low Cost Mobile Phones
14/09/2009
Stentys to disclose results of 'APPOSITION I' clinical study, world's first to treat acute myocardial infarction (AMI) with a self-expanding stent
14/09/2009
Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)
15/09/2009
Myriad Group Acquires Xumii, Inc.
22/09/2009
Myriad Appoints Former Nokia Chief Technologist Benoit Schillings as Chief Technical Officer
22/09/2009
UPEK Expands Biometric Market with Launch of New TouchChip® Fingerprint Solutions
23/09/2009
Myriad Group Reports EBITDA of USD 11 Million for 2009 H1
28/09/2009
Addex complète le recrutement d’un premiere essai clinique intermédiare sur le RGO
28/09/2009
Addex completes enrollment of first mid-stage clinical GERD trial
28/09/2009
Upek launches new product line optimized for mobile phone applications
01/10/2009
CONNECTHINGS, INSIDE Contactless and Sagem Wireless Receive Grant from French Government for First Wave-Me Services
01/10/2009
Sofinnova Partners annonce un accord portant sur la cession de Fovea Pharmaceuticals à Sanofi Aventis
01/10/2009
Sofinnova Partners announces an agreement to sell Fovea Pharmaceuticals to Sanofi Aventis
01/10/2009
Ablynx receives milestone payment as part of its strategic alliance with Boehringer Ingelheim
06/10/2009
PUMA partners with Sagem Wireless to launch PUMA Mobile Phone
06/10/2009
Orexo confirms FDA acceptance of Abstral filing
12/10/2009
Crescendo Biologics Raises £4.5 million in Seed-Funding Led by Sofinnova Partners
12/10/2009
NOXXON Pharma AG announces excellent preliminary phase I trial results for Spiegelmer® NOX-E36 - good safety and pharmacodynamic profile and additional good subcutaneous bioavailability
12/10/2009
Ablynx and Domantis settle their dispute and stop the arbitration process
15/10/2009
Protector Suite 2009 Software Adds Support for Windows 7 and the Windows Biometric Framework
15/10/2009
MicroPass 5100 “ICAO Lite” Products Compete for Best Identification Solution
15/10/2009
Accent - Itron Selects Accent Single Chip Solution for Smart Metering Applications
16/10/2009
Flexion Therapeutics Raises $33 Million in Series A Financing
19/10/2009
Endotis Pharma has initiated a Phase I program with the neutralizable anticoagulant EP217609 and its specific antidote avidin, and signed a manufacturing and co-development agreement with Sigma-Tau for avidin
21/10/2009
Largest Retail Deployment of Contactless Loyalty Sticker Technology in France
22/10/2009
Movetis obtains EU authorisation for the commercialisation of Resolor® (prucalopride). First launch of Resolor anticipated in Q1 2010.
23/10/2009
Le cabinet d'analystes Gartner vient de classer blueKiwi Software comme entreprise "Visionnaire" dans son Magic Quadrant 2010 sur les Réseaux Sociaux d'Entreprise ("Social Software in the Workplace 2010")
26/10/2009
Sofinnova Partners Leads $12 Million Series A Round in DNP Green Technology
26/10/2009
Sofinnova Partners, principal investisseur dans la première levée de fonds de 12 millions de dollars de DNP Green Technology
27/10/2009
Stentys expands Scientific Advisory Board (SAB) on heels of reporting successful clinical trial results for world's first self-expanding stent to treat AMI
27/10/2009
Sagem Wireless collaborates with CRYSTALLIZED™ – Swarovski Elements
03/11/2009
Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference
03/11/2009
Inside Contactless open Asia testing facility
02/11/2009
NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12
02/11/2009
Chiffre d’affaires 3ème trimestre 2009
16/11/2009
Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
18/11/2009
Ablynx achieves third milestone in drug discovery and development collaboration
17/11/2009
UPEK Announces EikonTouch™ USB Fingerprint Readers
19/11/2009
INSIDE Contactless wins in Semiconductor, Electronic and Components Category
03/12/2009
Movetis raises targeted €85 million in successful Initial Public Offering on Euronext Brussels
04/12/2009
First patient enrolled in randomized study of Stentys self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI)
03/12/2009
NOXXON Pharma AG Achieves Milestone in Partnership with Eli Lilly and Company
03/12/2009
Ablynx will receive further milestone payments of €3 million as part of its strategic alliance with Boehringer Ingelheim
03/12/2009
Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.
08/12/2009
mydeco.com Hires Ex-Google Product Manager
04/12/2009
Endotis Pharma presents Phase I clinical trials results for EP42675, a first-inclass synthetic parenteral anticoagulant, at the 51st Annual Meeting of the American Society of Hematology
02/11/2009
Endotis Pharma forms a strategic alliance with Catalent Pharma Solutions for the development of oral formulations of synthetic oligosaccharides and initiates preclinical development of EP37151, a first in-class oral anticoagulant
14/12/2009
Ablynx initiates Phase I for ALX-0141 (ANTI-RANKL)
14/12/2009
Addex ends migraine prevention study Conference call tomorrow at 2pm CET (8am ET)
23/12/2009
Sofinnova Partners annonce sa troisième cession de plus de 500 millions de dollars pour l’année 2009
23/12/2009
Novexel to be acquired by AstraZeneca
26/11/2009
MasterCard Canada Brings PayPass™ Payments to BlackBerry Smartphones
23/12/2009
Sofinnova Partners Announces for the Third Time in 2009 a Trade Sale over 500 million dollars
23/12/2009
Movetis raises a total of €97.75m via an additional €12.75 million Over-allotment Option
22/12/2009
Ablynx demonstrates proof-of-concept by biomarker for its anti-thrombotic ALX-0081

Click here for the site of Sofinnova Ventures, our sister firm in San Francisco http://www.sofinnova.com